Variant report

Variant	esv3693273
Chromosome Location	chr19:41983822-42006714
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:78)
CpG islands
(count:0)
Chromatin interactive
region (count:3)
LncRNA
region (count:26)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:78 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:41985894-41986022	K562	blood:	n/a	n/a
2	ATF1	chr19:41985515-41985820	K562	blood:	n/a	n/a
3	BACH1	chr19:41985825-41985834	K562	blood:	n/a	n/a
4	BHLHE40	chr19:41986254-41986585	K562	blood:	n/a	n/a
5	BHLHE40	chr19:41985631-41985823	K562	blood:	n/a	n/a
6	CBX3	chr19:41985547-41986099	K562	blood:	n/a	n/a
7	CEBPB	chr19:41992919-41993068	HepG2	liver:	n/a	n/a
8	CEBPB	chr19:41992465-41992478	H1-hESC	embryonic stem cell:	n/a	n/a
9	CEBPB	chr19:41992890-41993261	HepG2	liver:	n/a	chr19:41993068-41993079
10	CEBPB	chr19:41992986-41993092	IMR90	lung:	n/a	chr19:41993068-41993079
11	CEBPB	chr19:41992290-41992562	HepG2	liver:	n/a	n/a
12	CEBPB	chr19:41992947-41993198	A549	lung:	n/a	chr19:41993068-41993079
13	CEBPB	chr19:41992260-41992553	A549	lung:	n/a	n/a
14	CTCF	chr19:41984380-41984530	GM06990	blood:	n/a	n/a
15	CTCF	chr19:41992387-41992397	Kidney_OC	kidney:	n/a	n/a
16	CTCF	chr19:41984280-41984430	HEK293	kidney:	n/a	n/a
17	CTCF	chr19:41984200-41984350	A549	lung:	n/a	chr19:41984245-41984254 chr19:41984245-41984258
18	CTCF	chr19:41984420-41984570	A549	lung:	n/a	n/a
19	CTCF	chr19:41990980-41991130	A549	lung:	n/a	n/a
20	E2F6	chr19:41985892-41986040	K562	blood:	n/a	n/a
21	E2F6	chr19:42006624-42008253	A549	lung:	n/a	n/a
22	E2F6	chr19:41986216-41986489	K562	blood:	n/a	n/a
23	E2F6	chr19:41986291-41986500	K562	blood:	n/a	n/a
24	EP300	chr19:41985848-41986019	K562	blood:	n/a	n/a
25	FOS	chr19:41985798-41986124	MCF10A-Er-Src	breast:	n/a	chr19:41985971-41985982
26	FOS	chr19:41985864-41986064	MCF10A-Er-Src	breast:	n/a	chr19:41985971-41985982
27	FOS	chr19:41984858-41986274	HUVEC	blood vessel:	n/a	chr19:41985971-41985982 chr19:41985559-41985568
28	FOS	chr19:41985833-41986024	MCF10A-Er-Src	breast:	n/a	chr19:41985971-41985982
29	FOS	chr19:41985870-41986108	MCF10A-Er-Src	breast:	n/a	chr19:41985971-41985982
30	FOXA1	chr19:41992948-41993177	HepG2	liver:	n/a	n/a
31	FOXA1	chr19:41992958-41993164	HepG2	liver:	n/a	n/a
32	FOXA2	chr19:41992925-41993149	HepG2	liver:	n/a	n/a
33	GATA2	chr19:41984810-41986322	HUVEC	blood vessel:	n/a	chr19:41985224-41985238 chr19:41985225-41985234 chr19:41985222-41985238
34	HCFC1	chr19:41985853-41986038	K562	blood:	n/a	n/a
35	HEY1	chr19:41985909-41986152	K562	blood:	n/a	n/a
36	JUN	chr19:41985022-41986193	HUVEC	blood vessel:	n/a	chr19:41985559-41985568
37	JUN	chr19:41985371-41986377	K562	blood:	n/a	chr19:41985559-41985568
38	JUND	chr19:41985816-41986158	K562	blood:	n/a	n/a
39	MAFK	chr19:41993012-41993058	HepG2	liver:	n/a	n/a
40	MAFK	chr19:41985846-41986110	K562	blood:	n/a	n/a
41	MAX	chr19:41986236-41986626	ECC-1	luminal epithelium:	n/a	n/a
42	MAX	chr19:41985511-41986176	K562	blood:	n/a	n/a
43	MAX	chr19:41985658-41985683	K562	blood:	n/a	n/a
44	MAX	chr19:42006587-42008026	A549	lung:	n/a	chr19:42007171-42007180 chr19:42007171-42007180 chr19:42007171-42007180
45	MAX	chr19:41986225-41986567	K562	blood:	n/a	n/a
46	MYC	chr19:41985915-41986064	MCF10A-Er-Src	breast:	n/a	n/a
47	MYC	chr19:41985180-41985193	HUVEC	blood vessel:	n/a	n/a
48	MYC	chr19:41985676-41986052	HUVEC	blood vessel:	n/a	n/a
49	MYC	chr19:41985162-41985172	HUVEC	blood vessel:	n/a	n/a
50	MYC	chr19:41985639-41986039	K562	blood:	n/a	n/a

No data

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:41944061..41946977-chr19:42000429..42002001,2	K562	blood:
2	chr19:41945911..41947481-chr19:41988789..41990689,2	K562	blood:
3	chr19:41944280..41946189-chr19:42004239..42006678,2	K562	blood:

(count:26 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ATP5SL-1	chr19:42000448-42001335	ENSG00000249527
2	lnc-ATP5SL-1	chr19:42006494-42006554	ENSG00000249527
3	lnc-ATP5SL-1	chr19:42006494-42006559	ENSG00000249527
4	lnc-ATP5SL-1	chr19:42006494-42006554	ENSG00000249527
5	lnc-ATP5SL-1	chr19:42006494-42006538	NONHSAT066457
6	lnc-ATP5SL-1	chr19:42006494-42006554	ENSG00000267107.2
7	lnc-ATP5SL-1	chr19:42006494-42006545	NONHSAT066458
8	lnc-ATP5SL-1	chr19:41985040-41985192	NONHSAT066459
9	lnc-ATP5SL-1	chr19:41984989-41985192	ENSG00000267107.2
10	lnc-ATP5SL-1	chr19:42006494-42006539	ENSG00000267107.2
11	lnc-ATP5SL-1	chr19:41984989-41985192	NONHSAT066451
12	lnc-ATP5SL-1	chr19:42001210-42001335	NONHSAT066451
13	lnc-ATP5SL-1	chr19:41984989-41985049	ENSG00000267107.2
14	lnc-ATP5SL-1	chr19:41984989-41985192	NONHSAT066453
15	lnc-ATP5SL-1	chr19:42001210-42001335	ENSG00000267107.2
16	lnc-ATP5SL-1	chr19:42001210-42001338	NONHSAT066459
17	lnc-ATP5SL-1	chr19:42006494-42006540	NONHSAT066451
18	lnc-ATP5SL-1	chr19:41984989-41985049	ENSG00000267107.2
19	lnc-ATP5SL-1	chr19:41984451-41985192	NONHSAT066458
20	lnc-ATP5SL-1	chr19:41984451-41985192	NONHSAT066457
21	lnc-ATP5SL-1	chr19:42006494-42006554	NONHSAT066453
22	lnc-ATP5SL-1	chr19:42000448-42001335	ENSG00000267107.2
23	lnc-ATP5SL-1	chr19:41984989-41985192	ENSG00000249527
24	lnc-ATP5SL-1	chr19:41984989-41985051	ENSG00000267107.2
25	lnc-ATP5SL-1	chr19:41984989-41985192	ENSG00000249527
26	lnc-ATP5SL-1	chr19:42001210-42001335	NONHSAT066458

No data

Variant related genes	Relation type
ENSG00000267107	TF binding region
ENSG00000105341	chromatin interactions
SPTBN1	miRNA target sites
TMED7	miRNA target sites
EZH2	miRNA target sites
CHST11	miRNA target sites
CNN3	miRNA target sites
PRSS21	miRNA target sites

Extended variants
information (count: 941 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:941 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2005832	chr19:41983822-41983823	Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs143835859	chr19:41983824-41983825	Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs370303669	chr19:41983829-41983830	Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs181554128	chr19:41983835-41983836	Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs376666920	chr19:41983837-41983838	Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs186516592	chr19:41983847-41983848	Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs587750008	chr19:41983848-41983849	Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs114480425	chr19:41983860-41983861	Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs372440506	chr19:41983895-41983896	Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs191271538	chr19:41983914-41983915	Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs144358554	chr19:41983952-41983953	Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs60488168	chr19:41983957-41983958	Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs56717974	chr19:41983966-41983967	Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs587623043	chr19:41983981-41983982	Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs587686169	chr19:41983989-41983990	Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs375574769	chr19:41983999-41984000	Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs377081937	chr19:41984034-41984035	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs182590115	chr19:41984071-41984072	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs587640603	chr19:41984077-41984078	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs187763501	chr19:41984078-41984079	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs371402489	chr19:41984111-41984112	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs192016852	chr19:41984118-41984119	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs12462093	chr19:41984128-41984129	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
24	rs587699480	chr19:41984135-41984136	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs374685798	chr19:41984137-41984138	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs148137063	chr19:41984139-41984140	Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs35944634	chr19:41984216-41984217	Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs587712964	chr19:41984228-41984229	Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs587631408	chr19:41984234-41984235	Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs368067205	chr19:41984238-41984239	Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs183523339	chr19:41984275-41984276	Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs587617339	chr19:41984301-41984302	Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs141970167	chr19:41984380-41984381	Flanking Active TSS Bivalent/Poised TSS Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs60008265	chr19:41984407-41984408	Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs57501168	chr19:41984429-41984430	Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs587655671	chr19:41984437-41984438	Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs368294991	chr19:41984458-41984459	Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
38	rs117561230	chr19:41984459-41984460	Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
39	rs145111713	chr19:41984530-41984531	Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
40	rs587695810	chr19:41984531-41984532	Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
41	rs371933566	chr19:41984543-41984544	Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
42	rs77674170	chr19:41984552-41984553	Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
43	rs116936004	chr19:41984570-41984571	Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
44	rs587754648	chr19:41984575-41984576	Active TSS Flanking Active TSS Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
45	rs376849609	chr19:41984602-41984603	Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
46	rs587656682	chr19:41984710-41984711	Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
47	rs587707621	chr19:41984722-41984723	Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
48	rs587775555	chr19:41984749-41984750	Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
49	rs10420478	chr19:41984782-41984783	Flanking Active TSS Active TSS Bivalent/Poised TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
50	rs587664049	chr19:41984877-41984878	Flanking Active TSS Active TSS Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Genital abnormality	22378287	CNVD
Hypospadia	22378287	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Astrocytoma	22246337	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	22522925	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:152 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:41983000-41984000	Weak transcription	Right Atrium	heart
2	chr19:41983000-41986400	Weak transcription	Spleen	Spleen
3	chr19:41983400-41984000	Enhancers	Fetal Muscle Leg	muscle
4	chr19:41983400-41986400	Flanking Active TSS	HUVEC	blood vessel
5	chr19:41983600-41984200	Enhancers	Left Ventricle	heart
6	chr19:41983600-41985200	Active TSS	Lung	lung
7	chr19:41983800-41984600	Bivalent/Poised TSS	Fetal Muscle Trunk	muscle
8	chr19:41983800-41985000	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
9	chr19:41984000-41984200	Bivalent Enhancer	Adipose Nuclei	Adipose
10	chr19:41984000-41984200	Weak transcription	Fetal Muscle Leg	muscle
11	chr19:41984000-41984200	Enhancers	Right Atrium	heart
12	chr19:41984200-41984400	Bivalent/Poised TSS	Fetal Stomach	stomach
13	chr19:41984200-41984400	Flanking Active TSS	Left Ventricle	heart
14	chr19:41984200-41984800	Bivalent/Poised TSS	Right Ventricle	heart
15	chr19:41984200-41985000	Active TSS	Fetal Muscle Leg	muscle
16	chr19:41984200-41985600	Active TSS	Right Atrium	heart
17	chr19:41984200-41986400	Active TSS	Ovary	ovary
18	chr19:41984400-41984600	Active TSS	Adipose Nuclei	Adipose
19	chr19:41984400-41984800	Active TSS	Left Ventricle	heart
20	chr19:41984400-41985000	Active TSS	Fetal Stomach	stomach
21	chr19:41984400-41985000	Active TSS	Skeletal Muscle Male	skeletal muscle
22	chr19:41984600-41985000	Flanking Active TSS	Adipose Nuclei	Adipose
23	chr19:41984600-41985200	Active TSS	Fetal Muscle Trunk	muscle
24	chr19:41984800-41985000	Flanking Active TSS	Left Ventricle	heart
25	chr19:41984800-41985000	Flanking Active TSS	Right Ventricle	heart
26	chr19:41985000-41985400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
27	chr19:41985000-41986200	Weak transcription	Left Ventricle	heart
28	chr19:41985000-41986600	Enhancers	Adipose Nuclei	Adipose
29	chr19:41985000-41986600	Weak transcription	Skeletal Muscle Male	skeletal muscle
30	chr19:41985200-41985600	Weak transcription	Fetal Muscle Trunk	muscle
31	chr19:41985200-41986800	Weak transcription	Lung	lung
32	chr19:41985400-41986000	Enhancers	Fetal Heart	heart
33	chr19:41985400-41986200	Flanking Active TSS	K562	blood
34	chr19:41985400-41986400	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
35	chr19:41985600-41986600	Weak transcription	Right Atrium	heart
36	chr19:41986200-41986400	Active TSS	Left Ventricle	heart
37	chr19:41986200-41986800	Enhancers	K562	blood
38	chr19:41986400-41986800	Enhancers	Spleen	Spleen
39	chr19:41986400-41987000	Flanking Active TSS	Left Ventricle	heart
40	chr19:41986400-41987000	Enhancers	HUVEC	blood vessel
41	chr19:41986400-41987400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
42	chr19:41986600-41986800	Bivalent Enhancer	Adipose Nuclei	Adipose
43	chr19:41986600-41987000	Enhancers	Right Atrium	heart
44	chr19:41986600-41987000	Enhancers	Right Ventricle	heart
45	chr19:41986600-41987200	Enhancers	Skeletal Muscle Male	skeletal muscle
46	chr19:41986800-41987000	Flanking Bivalent TSS/Enh	Adipose Nuclei	Adipose
47	chr19:41986800-41987400	Enhancers	Lung	lung
48	chr19:41986800-41988400	Weak transcription	Spleen	Spleen
49	chr19:41987000-41987200	Bivalent Enhancer	Adipose Nuclei	Adipose
50	chr19:41987000-41987200	Enhancers	Fetal Muscle Trunk	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links